DIURNAL BLOOD PRESSURE PROFILE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Download full text PDF
Issue: 
4
Year: 
2016

Professor N. Shilkina (1), MD; I. Dryazhenkova (2), MD 1 -Yaroslavl State Medical University 2 -Railway Clinical Hospital at the Yaroslavl Station, OAO «RZhD»

Estimation of diurnal blood pressure (BP) variability in patients with systemic lupus erythematosus established a relationship of intracardiac hemodynamic variables to diurnal BP monitoring parameters.

Keywords: 
rheumatology
systemic lupus erythematosus
hypertension
diurnal blood pressure



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Bojtsov S.A. Vzaimosvjazi arterioskleroza, ateroskleroza i arterial' noj gipertonii – staryj vopros v svete novyh dannyh // Ter. arh. – 2009; 81 (12): 5–11.
  2. Chazova I.E., Oschepkova E.V. Rezul'taty realizatsii programmy po bor' be s arterial'noj gipertoniej v Rossii v 2002–2012 // Ter. arh. – 2013; 85 (1): 4–10.
  3. Danilov N.M., Chazova I.E., Savchenko A.P. Renovaskuljarnaja gipertenzija: diagnostika i lechenie // Sistemnye gipertenzii. – 2009; 1: 71–3.
  4. Gogin E.E. Vybor lechenija u bol'nyh arterial'noj gipertoniej-terapija simptomaticheskaja i bazisnaja, standartnaja i situatsionnaja. Treatment of hypertension // Ter. arh. – 2012; 84 (4): 41–6.
  5. Belenkov Ju.N., Privalova E.V., Danilogorskaja Ju.A. Remodelirovanie sosudistogo rusla u bol'nyh arterial'noj gipertenziej: vozmozhnosti dia-gnostiki i korrektsii // Kardiologija. – 2012; 52 (6): 67–71.
  6. Zaharova E.G., Fursov A.N., Potehin M.I. Izmenenie techenija giperto nicheskoj bolezni za poslednie 25 let // Klin. med. – 2013; 91 (8): 36–40.
  7. Rothwell P., Howard S., Doln E. et al. Prognostic significance of visit-to visit variability, maximum systolic blood pressure, and episodic hypertension // Lancet. – 2010; 375: 895–905.
  8. Ostroumova O.D. Variabel'nost' arterial'nogo davlenija i risk oslozhnenij pri arterial'noj gipertonii // Ter. arh. – 2012; 84 (10): 91–7.Karpov Ju.A. Novye Rossijskie rekomendatsii po arterial'noj giper tonii – prioritet kombinirovannoj terapii // Ter. arh. – 2012; 84 (1): 61–4.
  9. Webb A., Fischer U., Mehta Z. et al. Effects of antihypertensive-drug class on interindividual variation in BP and risk of stroke: a systematic rewiew and meta-analysis // Lancet. – 2010; 375: 906–15.
  10. Rothwell P., Webb A. Effect of dose and combination of antihypertensives on interindividual blood pressure variability: A systematic review // Stroke. – 2011; 42: 2860–5.
  11. Demina A.B., Radenska-Lopovok S.G., Folomeeva O.M. i dr. Prichiny smerti bol'nyh s revmaticheskimi zabolevanijami v Moskve // Ter. arh. – 2005; 77 (4): 77–82.
  12. Popkova T.V., Novikova D.S., Nasonov E.L. Kardiovaskuljarnye fakto ry riska pri revmaticheskih zabolevanijah: svjaz' s vospaleniem // Bolezni serdtsa i sosudov. – 2010; 2: 46–53.
  13. Wajed J., Ahmad Y., Duttington P. et al. Prevention of cardiovascular disease in systemic lupus erythematosus – proposed guidelines for risk factor management // Rheumatology. – 2004; 43: 7–12.
  14. Barnes E., Narain S., Naranjo A. et al. High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk // Lupus. – 2005; 14 (8): 576–82.
  15. Yang L., Tao J., Wang Y. et al. Prevalence and correlation of conventional 16. and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients // J. Eur. Acad. Dermatol. Venerol. – 2011; 26: 95–101.
  16. Sinicato N., da Silva Cardoso P., Appenzeller S. Risk factors in cardiovascular disease in systemic lupus erthematosus // Curr. Cardiol. Rev. – 2013; 9 (1): 15–9.
  17. Tso T., Huang W., Huang H. et al. Relationship of plasma interleukin-18 concentrations to traditional and nontraditional cardiovascular risk factors in patients with systemic lupus erythematosus // Rheumatology. – 2006; 45: 1148–53.
  18. Haque S., Mirjafari H., Bruce I. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus // Curr. Opin. Lipidol. – 2008; 19: 338–43.